The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO

S. Di Cosimo, C. Campbell, H. A. Azim, G. Galli, G. Bregni, G. Curigliano, C. Criscitiello, M. Izquierdo, L. de la Pena, D. Fumagalli, L. Fein, J. Vinholes, W. M.J. Ng, M. Colleoni, A. Ferro, B. J. Naume, A. Patel, J. Huober, M. J. Piccart-Gebhart, J. BaselgaE. de Azambuja

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO'. Together they form a unique fingerprint.

Medicine & Life Sciences